Notch Therapeutics: Funding, Investors & Team (Oct 2026)
Notch Therapeutics, founded in 2018 and based in Toronto, Canada, is innovating in immune cell therapy by creating a next-generation pipeline focused on targeting cancer cells. The company's unique T-cell production platform allows precise control of Notch signaling, crucial for T-cell development, through advanced product design and industrial processes. This control over Notch signaling overcomes key challenges in cell therapy development, enabling the consistent manufacture of a sustainable supply of therapeutic T cells.
Notch Therapeutics has raised $15.5M across 1 funding round on record, the most recent an undisclosed round of $15.5M announced in Jun 2024.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Notch Therapeutics Company Profile and Key Stats
Latest funding round on record: Jun 2024.
Notch Therapeutics Funding Rounds
Notch Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Notch Therapeutics Funding Compared to Other Biotechnology Startups
Notch Therapeutics' latest round of $15.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Notch Therapeutics in Biotechnology and Toronto
Companies Similar to Notch Therapeutics
Tydra Labs is a biotechnology company that transforms crustacean shell waste into chitin and bio-products.
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
Notch Therapeutics Funding FAQs
What does Notch Therapeutics do?
Notch Therapeutics, founded in 2018 and based in Toronto, Canada, is innovating in immune cell therapy by creating a next-generation pipeline focused on targeting cancer cells. The company's unique T-cell production platform allows precise control of Notch signaling, crucial for T-cell development, through advanced product design and industrial processes. This control over Notch signaling overcomes key challenges in cell therapy development, enabling the consistent manufacture of a sustainable supply of therapeutic T cells.
How much funding has Notch Therapeutics raised?
Notch Therapeutics has raised $15.5M across 1 round on record. The most recent is an undisclosed round of $15.5M announced in Jun 2024.
When did Notch Therapeutics last raise funding?
Notch Therapeutics' most recent funding round on record is an undisclosed round of $15.5M, announced in Jun 2024.
Who founded Notch Therapeutics?
FundedIQ lists Shreya Shukla (Founder) at Notch Therapeutics.
Where is Notch Therapeutics headquartered?
Notch Therapeutics is based in Toronto, Ontario, Canada.
How many employees does Notch Therapeutics have?
Notch Therapeutics is in the 101-250 employee band.
How does Notch Therapeutics' funding compare to other Biotechnology startups?
Notch Therapeutics' latest round of $15.5M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Notch Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Notch Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.